Seminars in Nuclear Medicine
Volume 32, Issue 1 , Pages 70-76 , January 2002

18F FDG uptake in the large arteries: A correlation study with the atherogenic risk factors

References 

  1. Yun M, Yeh D, Araujo L, et al. F-18 FDG uptake in the large arteries: A new observation. Clin Nucl Med. 2001;26:314–319
  2. Mochizuki Y, Fujii H, Yasuda S, et al. FDG accumulation in aortic walls. Clin Nucl Med. 2001;26:68–69
  3. Stary H, Blankenhorn D, Chandler A, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1992;85:391–405
  4. Bierman E. Disorders of the vascular system. In: Harrison's Principles of Internal Medicine. McGraw Hill; 1994;p. 1106–1116
  5. Yamada S, Kubota K, Kubota R, et al. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med. 1995;36:1301–1306
  6. (abstr) Vallabhajosula S, Machac J, Knesaurek K, et al. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose. J Nucl Med. 1996;37:38
  7. (abstr) Machac J, Zhang Z, Nunez R, et al. 18 F fluorodeoxyglucose uptake in human thoracic aortas assessed in vivo by positron emission tomography. J Nucl Med. 2001;42:54P
  8. Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999;340:115–126
  9. Wilson P, D'Agostino R, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  10. Karp J, Muehllehner G, Qu H, et al. Singles transmission in volume-imaging PET with a 137Cs source. Phys Med Biol. 1995;40:929–944
  11. Bedigian M, Benard F, Smith R, et al. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction. Eur J Nucl Med. 1998;25:659–661
  12. Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics. 1999;19:61–77
  13. Stumpe K, Dazzi H, Schaffner A, et al. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27:822–832
  14. Hara M, Goodman P, Leder R. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr. 1999;23:16–18
  15. Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology. 1999;38:444–447
  16. Petermans J. Prevalence of disease of the large arteries in an elderly Belgian population: Relationship with some metabolic factors. Acta Cardiol. 1984;39:365–372
  17. Stary H, Chandler A, Dinsmore R, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355–1374
  18. Bilato C, Crow M. Atherosclerosis and the vascular biology of aging. Aging (Milano). 1996;8:221–234
  19. Braunwald E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–1369
  20. Stary H, Chandler A, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committe on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–2478
  21. Galbraith J, Murphy M, de Soyza N. Coronary angiogram interpretation. Interobserver variability. JAMA. 1978;240:2053–2056
  22. Leape L, Park R, Bashore T, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J. 2000;139:106–113
  23. Nissen S, Yock P. Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation. 2001;103:604–616
  24. Erbel R, Ge J, Bockisch A, et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: A prospective study in patients with angina pectoris. Eur Heart J. 1996;17:880–889
  25. Lee D, Eigler N, Luo H, et al. Effect of intracoronary ultrasound imaging on clinical decision making. Am Heart J. 1995;129:1084–1093
  26. Potkin B, Bartorelli A, Gessert J, et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation. 1990;81:1575–1585
  27. Siegel R, Ariani M, Fishbein M, et al. Histopathologic validation of angioscopy and intravascular ultrasound. Circulation. 1991;84:109–117
  28. Saeed M, Wendland M, Higgins C. Blood pool MR contrast agents for cardiovascular imaging. J Magn Reson Imaging. 2000;12:890–898
  29. Yucel E, Anderson C, Edelman R, et al. AHA scientific statement. Magnetic resonance angiography: Update on applications for extracranial arteries. Circulation. 1999;100:2284–2301
  30. Toussaint J, LaMuraglia G, Southern J, et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932–938
  31. Helft G, Worthley S, Fuster V, et al. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: An in vivo study in rabbits. J Am Coll Cardiol. 2001;37:1149–1154
  32. Raggi P. Coronary calcium on electron beam tomography imaging as a surrogate marker of coronary artery disease. Am J Cardiol. 2001;87:27A–34A
  33. Budoff M, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study. Circulation. 1996;93:898–904
  34. Budoff M, Brundage B. Electron beam computed tomography: Screening for coronary artery disease. Clin Cardiol. 1999;22:554–558
  35. Lees R, Lees A, Strauss H. External imaging of human atherosclerosis. J Nucl Med. 1983;24:154–156
  36. Lees A, Lees R, Schoen F, et al. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis. 1988;8:461–470
  37. Fischman A, Rubin R, Khaw B, et al. Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. J Nucl Med. 1989;30:1095–1100
  38. Vallabhajosula S, Goldsmith S. 99mTc-low density lipoprotein: Intracellularly trapped radiotracer for noninvasive imaging of low density lipoprotein metabolism in vivo. Semin Nucl Med. 1990;20:68–79
  39. Hardoff R, Braegelmann F, Zanzonico P, et al. External imaging of atherosclerosis in rabbits using an 123I-labeled synthetic peptide fragment. J Clin Pharmacol. 1993;33:1039–1047
  40. Narula J, Petrov A, Bianchi C, et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments. Circulation. 1995;92:474–484
  41. Chakrabarti M, Cheng K, Spicer K, et al. Biodistribution and radioimmunopharmacokinetics of 131I-Ama monoclonal antibody in atherosclerotic rabbits. Nucl Med Biol. 1995;22:693–697
  42. Dinkelborg L, Duda S, Hanke H, et al. Molecular imaging of atherosclerosis using a technetium-99m-labeled endothelin derivative. J Nucl Med. 1998;39:1819–1822
  43. Iuliano L, Signore A, Vallabajosula S, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis. 1996;126:131–141
  44. Vallabhajosula S, Fuster V. Atherosclerosis: Imaging techniques and the evolving role of nuclear medicine. J Nucl Med. 1997;38:1788–1796
  45. Mettinger K, Larsson S, Ericson K, et al. Detection of atherosclerotic plaques in carotid arteries by the use of 123I-fibrinogen. Lancet. 1978;1:242–244
  46. Uehara A, Isaka Y, Hashikawa K, et al. Iodine-131-labeled fibronectin: Potential agent for imaging atherosclerotic lesion and thrombus. J Nucl Med. 1998;29:1264–1267
  47. Stratton J, Cerqueira M, Dewhurst T, et al. Imaging arterial thrombosis: Comparison of technetium-99m-labeled monoclonal antifibrin antibodies and indium-111-platelets. J Nucl Med. 1994;35:1731–1737
  48. Stratton J, Dewhurst T, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation. 1995;92:3113–3121
  49. Smyth J, Dodd P, Walker M. Indium-111 platelet scintigraphy in vascular disease. Br J Surg. 1995;82:588–595
  50. Moriwaki H, Matsumoto M, Handa N, et al. Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography. Arterioscler Thromb Vasc Biol. 1995;15:2234–2240
  51. Slosman D, Spiliopoulos A, Keller A, et al. Quantitative metabolic PET imaging of a plasma cell granuloma. J Thorac Imaging. 1994;9:116–119
  52. Lewis P, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994;35:1647–1649
  53. Sugawara Y, Braun D, Kison P, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: Preliminary results. Eur J Nucl Med. 1998;25:1238–1243
  54. (abstr) Zhang Z, Machac J, Helft G, et al. Noninvasive serial monitoring of atherosclerotic progression and regression with FDG-PET in a rabbit model. J Nucl Med. 2000;41:7P
  55. Kullo I, Gau G, Tajik A. Novel risk factors for atherosclerosis. Mayo Clin Proc. 2000;75:369–380

PII: S0001-2998(02)80041-1

doi: 10.1053/snuc.2002.29279

Seminars in Nuclear Medicine
Volume 32, Issue 1 , Pages 70-76 , January 2002

Article Tools